Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Piramal Stays The M&A Course; Snaps Up Niche Mallinckrodt Assets

Executive Summary

India’s Piramal group continues its buying spree, snapping up Mallinckrodt’s intrathecal therapy business, as it seeks limited competition niches to plough deeper into the $20bn-plus global generic injectable hospital drugs market.

Advertisement

Related Content

Deal Watch: Best Value For Smaller Firms Lies In The Back-End
Piramal Builds GI Play With OTC Acquisitions

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register